FDA NDC Directory · JSON-LD · Markdown

Topiramate

NDC 70771-1315 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207382
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsTOPIRAMATE (25 mg/1)
Marketing started20180405
Package count5

External sources

Source: openFDA. Public-domain (CC0).